Wednesday, August 26, 2020

Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions

The management of metastatic cancer remains a major challenge in cancer therapy worldwide. The targeted delivery of chemotherapeutic drugs through rationally designed formulations is one potential therapeutic ...

from Most Recent Articles: Journal of Nanobiotechnology https://ift.tt/31sA6fl
via IFTTT

No comments:

Post a Comment